Clinical Trials Related to Geographic Atrophy

Related studies linked through entity extraction aliases.

A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy

Status: COMPLETED
Phase: PHASE2

A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy

Status: WITHDRAWN
Phase: PHASE1

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Status: COMPLETED
Phase: PHASE2

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy

Status: COMPLETED
Phase: PHASE1

Geographic Atrophy Treatment Evaluation

Status: TERMINATED
Phase: PHASE3

The Natural History of Geographic Atrophy Progression (GAP) Study

Status: TERMINATED
Phase: N/A

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Status: COMPLETED
Phase: PHASE2

OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

Status: COMPLETED
Phase: PHASE2